- Abstract:
-
Background: To control multidrug resistant tuberculosis (MDR-TB), the drug susceptibility profile is needed to guide therapy. Classical drug susceptibility testing (DST) may take up to 2 to 4 months. The GenoType® MTBDRplus test is a commercially available line-probe assay that rapidly detects Mycobacterium tuberculosis (MTB) complex, as well as the most common mutations associated with rifampin and isoniazid resistance.
Expand abstract
We assessed sensitivi... - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Publisher's version
- Publisher:
- BioMed Central Publisher's website
- Journal:
- BMC Infectious Diseases Journal website
- Volume:
- 10
- Pages:
- Article: 149
- Publication date:
- 2010-06-03
- Acceptance date:
- 2010-06-03
- DOI:
- EISSN:
-
1471-2334
- URN:
-
uuid:a1cf1671-d31d-410e-b436-b5b25a8aad09
- Source identifiers:
-
167178
- Local pid:
- pubs:167178
- Language:
- English
- Keywords:
- Copyright holder:
- Huyen et al.
- Copyright date:
- 2010
- Notes:
- © 2010 Huyen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Journal article
Validation of the GenoType®MTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South Vietnam
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record